-
Mashup Score: 1Extended Safety and Tolerability of Darolutamide for Nonmetastatic Castration-Resistant Prostate Cancer and Adverse Event Time Course in ARAMIS - 1 month(s) ago
This report examines darolutamide tolerability from extended follow-up for both the double-blind and open-label treatment periods of the phase III ARAMIS t
Source: academic.oup.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 13Clinical Value of Timely Targeted Therapy for Patients With Advanced Non–Small Cell Lung Cancer With Actionable Driver Oncogenes - 1 month(s) ago
This is the largest study to date to evaluate the clinical impact of different timing and treatment patterns of first-line targeted therapy in patients with adv
Source: academic.oup.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4Treatment and Prognosis of Male Breast Cancer: A Multicentric, Retrospective Study Over 11 Years in the Czech Republic - 2 month(s) ago
This study evaluated patient and disease characteristics, treatment, and prognosis of male breast cancer among patients registered with the Complex Oncological
Source: academic.oup.comCategories: General Medicine News, Onc News and JournalsTweet-
Based on this study involving male #breastcancer patients, unfavorable features were common but did not affect prognosis. However, the prognosis of HR+ disease can be negatively affected by AI monotherapy without castration therapy. @CharlesUniPRG #bcsm https://t.co/Iw1JMVNLML https://t.co/QAwdZoxIGL
-
-
Mashup Score: 2A Phase II Study of Rucaparib Monotherapy in Nonmetastatic, Hormone-Sensitive Prostate Cancer Demonstrating “BRCAness” Genotype (ROAR) - 2 month(s) ago
This article reports clinical trial results of a phase II trial assessing the efficacy of rucaparib in patients with high-risk biochemically recurrent nonmetast
Source: academic.oup.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 7Efficacy and Safety of Trifluridine/Tipiracil-Containing Combinations in Colorectal Cancer and Other Advanced Solid Tumors: A Systematic Review - 2 month(s) ago
The data reported here will inform treatment decision-making about the use of combination therapies that include trifluridine/tipiracil in the first-, second-,
Source: academic.oup.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 6The Oncologist - 2 month(s) ago
The Oncologist is committed to helping physicians excel in the constantly changing fields of oncology and hematology through the publication of timely reviews, original studies, and commentaries on important developments.
Source: academic.oup.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular Carcinoma - 2 month(s) ago
This pilot study explored whether using immunotherapy drugs in combination with locoregional therapies for patients with non-metastatic hepatocellular carcinoma
Source: academic.oup.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 8
This study retrospectively reviewed the outcomes of patients with advanced hepatocellular carcinoma receiving atezolizumab with bevacizumab (A + B) therapy at t
Source: academic.oup.comCategories: General Medicine News, Onc News and JournalsTweet-
'@MunafAlkadimi et al show real-world outcomes for pts w/ #HCC undergoing atezo+bev for 1st-line treatment. #PFS was similar to IMBRAVE 150; reduced #OS was attributed to older adult & nonWhite pts w/ moderate liver dysfunction. @DrSukeshiArora @doczohra1 https://t.co/bJT2RqvMYA https://t.co/P0pDLV8sFK
-
-
Mashup Score: 3Rural-Urban Disparities in Colorectal Cancer Screening, Diagnosis, Treatment, and Survivorship Care: A Systematic Review and Meta-Analysis - 2 month(s) ago
This article evaluates the literature on differences in colorectal cancer screening, stage at diagnosis, treatment, and survivorship care of patients in rural a
Source: academic.oup.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 71Consuming Patients’ Days: Time Spent on Ambulatory Appointments by People With Cancer - 3 month(s) ago
This study used real-time location system and geolocation data to assess how much time (in minutes) patients spent on attending clinic appointments. Even seemin
Source: academic.oup.comCategories: General Medicine News, Onc News and JournalsTweet
This extended safety and tolerability analysis from the phase III #ARAMIS trial involving #nmCRPC patients showed that #darolutamide was well-tolerated with no new safety signals observed. #prostatecancer @CarolinaUrology https://t.co/i98nMMQoXO https://t.co/aq9ujNBfyY